Introduction
Many human and murine cancers contain mutations in tumor suppressor genes, which often map to chromosomal regions that exhibit allelic loss or loss of heterozygosity. Allelic loss analysis is therefore a standard method to locate the regions carrying tumor suppressor genes (Knudson, 1985; Weinberg, 1991; Vogelstein and Kinzler, 1993) . Identi®cation of novel tumor suppressor genes is important for understanding the molecular mechanism underlying carcinogenesis, but only about 25 suppressor genes have been identi®ed. Mouse genetic systems oer a number of useful features for allelic loss analysis, including the availability of thousands of polymorphic markers and the ability to breed genetically uniform and informative hybrid mice that can provide an essentially unlimited number of tumors (Kemp et al., 1993; Dietrich et al., 1994) . Accordingly, several extensive analyses of tumors in F 1 hybrid mice have been reported. Hegi et al. (1994) studied lung carcinomas and revealed frequent allelic losses on a distal region on mouse chromosome 4 (which is homologous to human chromosome 1p36), where allelic losses were also frequently observed in mammary tumors (Radany et al., 1997) . Santos et al. (1996 Santos et al. ( , 1998 examined murine thymic lymphomas and suggested the existence of a putative tumor suppressor gene in a 0.6 cM region on chromosome 4. We also performed such analysis for murine thymic lymphomas that were induced by girradiation in F 1 hybrid mice and N 2 backcross mice between BALB/c and MSM strains (Matsumoto et al., 1998) . A genome-wide analysis identi®ed two chromosomal regions exhibiting frequent allelic loss. One, designated as TLSR12a (renamed as Tlsr4: thymic lymphoma suppressor region 4), is located within the 2.9 cM region between D12Mit53 and D12Mit279/233 on chromosome 12, while the other, TLSR16a (renamed as Tlsr5), is found in the vicinity of D16Mit122/D16Mit162 on chromosome 16. However, none of these candidate tumor suppressor regions in mouse tumors are physically delineated, and it is therefore dicult to re®ne the regions at the sequence level. Positional cloning of tumor suppressor genes requires not only genetic mapping but also physical mapping with YACs, BACs or other cloning vectors that provide sequence data of the candidate tumor suppressor regions.
In this paper we report the construction of a physical map of Tlsr4. The D12Mit279 locus in the vicinity of Tlsr4 showed allelic loss at a frequency of as high as 62% and the frequency was not aected by the presence or absence of a p53-de®cient allele in irradiated mice (Matsumoto et al., 1998) . Interestingly, the Tlsr4 interval on mouse chromosome 12 is homologous to human chromosome 14q32 ± 33 where frequent allelic losses have been found in a variety of tumors: ovarian tumors (Bandera, 1997) , colorectal carcinomas (Young et al., 1993) , neuroblastomas (Suzuki et al., 1989) and invasive bladder cancer (Chang et al., 1995) . Therefore, analysis of Tlsr4 may lead to isolation of a candidate of the tumor suppressor gene not only in Tlsr4 but also in the human 14q32-33 region. The physical map consists of 15 BAC clones covering Tlsr4 which contains informative boundaries of allelic losses relative to the ¯anking markers. This physical mapping has localized Tlsr4 to be within a 35 kb region. This region contained a NotI site, indicative of a nearby coding region.
Results
We previously performed a genome-wide allelic loss analysis for 245 informative thymic lymphomas that were induced by g-ray irradiation in F 1 hybrid and N 2 backcross mice between BALB/c and MSM strains. This analysis mapped the Tlsr4 (previously called Tlsr12a) region exhibiting frequent allelic loss to a 2.9 cM interval between the markers D12Mit53 and D12Mit279 on mouse chromosome 12 ( Figure  1a ). On the basis of this genetic data, we started the construction of a physical map in the vicinity of Tlsr4 region. Four probes of D12Mit53, D12Mit233, D12Mit279 and D12Mit80 were used as start points for screening a YAC library and eleven YAC clones were isolated. Their centromeric and telomeric ends were recovered using vectorette polymerase chain reaction (Riley et al., 1990) and sequenced to yield sequence-tagged sites (STSs). Two STS markers, Y11(II) and YE6(II), detected polymorphisms between the two strains ( Figure 1b) . Hence, the markers were used for ®ne mapping of a putative lymphoma suppressor gene within Tlsr4. In parallel, we obtained additional 116 lymphomas from F 1 mice between the BALB/c and MSM strains and these samples were also used for allelic loss mapping. Among 361 informative lymphomas examined in total, thirteen lymphomas and ®ve lymphomas still retained both alleles in the Y11(II) and YE6(II) marker sites, respectively ( Figure 1a ). Since 28 and 15 lymphomas showed retention of both alleles at D12Mit53 and D12Mit279, respectively, this indicated that the critical region of allelic loss was not between D12Mit53 and Y11(II) but between Y11(II) and D12Mit279 which was covered by a 700 kb YAC11 ( Figure 1a) .
Analysis of YAC11 revealed that it had internal deletion (data not shown). This suggested that eective isolation of candidates for the putative tumor suppressor gene needed to construct a BAC contig. We thus isolated 15 BAC clones using the Y11(II), YE6(II), YC3(II), D12Mi233 and D12Mit279 probes ( Figure 2a ). Each cloned DNA was digested with NotI, separated by pulsed-®eld gel electrophoresis (PFGE) and subjected to Southern hybridization for linking the clones. DNA fragments from 15 kb to 160 kb were observed in gels, some of which were the same, indicative of overlapping clones. of each clone by PCR (data not shown) revealed that they were grouped into one cluster to make up a contig (Figure 2a) . Polymorphisms within the region covered by the contig was required for further allelic loss mapping to position the critical region. Accordingly, ®ve polymorphic STSs of B19E(I), MCA1, B2N(I), B3N(II) and B3K(I) were obtained by sequence analysis of the BAC DNA followed by detecting variation between the two strains ( Figure 2a) .
Among the 361 lymphomas, 33 samples lost one allele at one or two of the three loci, D12Mit53, B2N(I) and D12Mit279, and therefore were useful to localize the commonly lost region. The remaining 218 lymphomas showed allelic losses in all marker loci from D12Mit53 to D12Mit279 and the 110 lymphomas retained both alleles in the loci. These 33 informative samples were subjected to allelic loss mapping using the ®ve BAC STS probes together with the two YACend probes. Figure 3 shows examples of allelic loss analysis with B2N(I). Only one lymphoma retained both alleles. Such analysis demonstrated that the frequency of allelic loss was highest in the B2N(I) locus (250/361: 69%). Comparison of the extent of allelic loss in the seven polymorphic sites revealed boundaries of allelic losses relative to the¯anking markers (Figure 4) . It indicated that the region between B2N(I) and B3N(II) was the only site to be consistently lost in these lymphomas. The region was 35 kb long from the pulsed-®eld gel electrophoresis analysis of BAC DNA (Figure 2 ).
Discussion
In this paper we present construction of the physical map in the vicinity of Tlsr4 which probably harbors a putative tumor suppressor gene and allelic loss mapping for 361 g-ray induced thymic lymphomas. Seventeen lymphomas gave allelic imbalance or controversial patterns of band loss probably due to contamination of normal tissues in tumor samples and these were excluded from the informative samples. The peak of allelic loss (69%) is in the vicinity of the B2N(I) locus on mouse chromosome 12 and a 35 kb interval between the B2N(I) and B3N(II) loci is an only site showing allelic loss in all of the 251 informative lymphomas examined (Figure 4) . The results suggest that Tlsr4 exists within the 35 kb interval. However, this may not be valid since there is only one lymphoma showing retention of both alleles at the B2N(I) locus. On the other hand, seven and four lymphomas exhibit the retention of both alleles at the MCA1 and B3N(II) sites¯anking to the B2N(I) locus, respectively. Therefore, it may be more reasonable to conclude that Tlsr4 exists probably in the 35 kb region and at least in an interval of about 100 kb between MCAI and B3N(II) covered by the B8L BAC. We have noticed that there is one sample with a homozygous deletion in the vicinity of Tlsr4. However, this did not give any information for localizing the critical region of Tlsr4 because the deleted region was as large as an interval between B19E(I) and D12Mit279 (data not shown).
Analysis of Tlsr4 on chromosome 12 in the mouse thymic lymphomas shows that there is only one peak region in the allelic loss frequency. This allows us to narrow down the Tlsr4 region. We are also making a physical map of the Tlsr5 region on chromosome 16. The result contrasts with that of Tlsr4. The allelic loss frequency does not exhibit a sharp peak, but the frequency is high in two or three peak areas (data not shown). The dierence in the two loci remains unclear. To our knowledge, the present paper is the ®rst report of successful construction of a high resolution physical map in murine tumors that contains informative boundaries of allelic losses relative to the¯anking markers.
In addition to the thymic lymphomas, our g-ray irradiation experiment has yielded 79 informative subcutaneous tumors in the F 1 hybrid and N 2 backcross mice. The tumors of epithelial origin also show allelic loss or allelic imbalance at a high frequency of 67% (53/79) at the YE6(II) locus (data not shown). This implies that the same gene in Tlsr4 may be relevant for the development of both thymic lymphomas and subcutaneous tumors. Zhuang et al. (1996) reported allelic loss analysis of mouse lymphomas induced by a carcinogenic agent, 2', 3'-dideoxycytidine-and 1, 3-butadiene. They found frequent allelic loss in the vicinity of Tlsr4. This suggests that the putative tumor suppressor gene in Tlsr4 is involved in the genesis of tumors induced by dierent carcinogens.
One NotI recognition sequence is present in the 35 kb interval. Approximately 90% of the NotI sites in human and mouse genomes are estimated to reside in CpG islands (Antequera and Bird, 1993) that are found associated with all examples of housekeeping genes and some of the tissue-speci®c genes (Bird, 1992) . This suggests the presence of a gene in the vicinity of the NotI site which might be a candidate for the tumor suppressor gene.
Although it is preliminary, analysis of the B8L BAC DNA has been performed by random DNA sequencing. It attained to a level of an average of onefold coverage. Some gaps especially in the 35 kb region were ®lled by primer-walk sequencing of selected subclones and the BAC DNA. The obtained sequences are being subjected to homology search for expressed sequence tags (ESTs) in data bases using the BLAST program. As a result, 16 ESTs have been mapped in this region. Some of the ESTs can be a candidate of a putative lymphoma suppressor gene in Tlsr4 and hence are being subjected to mutation analysis for lymphoma cDNA.
One EST has a sequence homologous to a human EST which is present in human chromosome 14q32. This indicates that Tlsr4 is syntenic to the human 14q32 region where frequent allelic losses have been found in various human tumors such as ovarian Figure 4 Allelic loss mapping of the Tlsr4 region using thymic lymphomas induced by g-irradiation. Open and solid bars represent the allelic loss of BALB/c allele and MSM allele, respectively. Circles indicate both alleles retained. The number of lymphomas showing allelic loss of all markers in this region is 218 (shown by a striped bar) and the number of lymphomas retaining both alleles is 110. The p53 genotype of mice bearing thymic lymphoma is shown in the second column; its dierence does not aect the extent of allelic loss region. The commonly lost region is indicated by a bar above markers. Numbers on a thin line below the bars indicate lymphomas retaining both alleles in 251 informative lymphomas examined cancers and neuroblastomas (Suzuki et al., 1989; Young et al., 1993; Chang et al., 1995; Bandera, 1997) . Therefore, a human homolog of the candidate tumor suppressor gene in Tlsr4 may be involved in the development of some of those human tumors, although the types of mouse and human tumors are dierent. This implication is based on the ®ndings that the dierent spectrum of tumors is observed in human and mouse carriers of germline mutations in the same gene and that there is a dierence in allelic loss frequencies of genes in human and mouse tumors of the same tissue origin (Okamoto et al., 1995; Jacks, 1996; Brown and Solomon, 1997) . This suggests that the physical map presented here is valuable not only for the isolation of genes in the Tlsr4 region but also for the identi®cation of a tumor suppressor gene in the human 14q32 region. Detailed analysis of the Tlsr4 region is in progress and the results will be reported elsewhere.
Materials and methods

Lymphomas and mice
The 245 informative thymic lymphomas used in this study were previously obtained from F 1 hybrid and N 2 backcross mice between BALB/c and MSM carrying a p53-de®cient allele (Matsumoto et al., 1998) . In this study additional 116 lymphomas were generated from the F 1 hybrid mice, about a half of which carried a p53-de®cient allele, by fractionated doses of g-ray irradiation, 2.5 Gy four times at a week interval, when the mice were at age of 4 weeks. MSM is an inbred strain derived from Japanese wild mice, Mus musculus molossinus (Bonhomme and Guenet, 1989) . A total of the 361 informative thymic lymphomas were used for allelic loss analysis
PCR analysis
Genuine DNA was extracted from normal brain and thymic lymphoma and subjected to polymerase chain reaction (PCR). Reaction was carried out by standard protocols. Aliquots of 5 ml of product were separated by electrophoresis on 4% NuSieve-agarose gel or on 8% polyacrylamide gel. Microsatellite markers used were synthesized according to sequences reported (Dietrich et al., 1996) . Other primer sequences are as follows: Y11(II), F-CTGAGCTTGTCTTCATCAGGA, R-TCAGCAACGATTCCATTCCCA; YE6(II), F-ACAGC-CCCATCTGTGTGATA, R-GAACAGCCTTCATTCTAA-GGG; B19E(I), F-GGCTTCCTACGAAGGTTTCT, R-AC-AGCCCTGTGGATGGTTTT; MCA1, F-GCTACAGGT-CACCTCTTAATG, R-AG CCCTTGG AT CTTCAG TCA; B2N(I), F-CCACAGAGCTTCTCAACTTG, R-TG ACA-GAGCAGT GGTTCTCG; B3N(II), F-GCAGTG ATGTAC-TA CA AGG G, R-GG CAC AACTG AA GCAA GG TG; B3K(I), F-CCATCACAACAGCAATGGCC, R-AAGTC-TAGTGCTTGGCAGAC.
Isolation of YACs and BACs and analysis of their linkage
YAC and BAC clones were isolated by PCR screening. Their libraries were purchased from Research Genetics, Inc. The size of clones was determined by pulsed-®eld gel electrophoresis. YAC ends were recovered using vectorette PCR (Riley et al., 1990) and subjected to sequence analysis. Each end of BAC inserts was directly sequenced and randomly isolated fragments of two BACs (B3N and B2N) were subjected to sequencing after the cloning process in pUC118 vector. PCR primers for the BAC ends and the BAC insert fragments were synthesized according to sequences obtained.
Pulsed-®eld gel electrophoresis of DNA DNA was prepared in agarose plugs as described (Hayashi et al., 1993) . The plugs were digested with a restriction enzyme, NotI, under the manufacturer's recommended conditions, and subjected to electrophoresis using a BioRad She Mapper apparatus.
Abbreviations YAC, yeast arti®cial chromosome; BAC, bacteria arti®cial chromosome
